Further processing options
Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis
Saved in:
Journal Title: | Haematologica |
---|---|
Authors and Corporations: | , , , , , , , , , , , , , , , |
In: | Haematologica, 102, 2017, 2, p. 327-335 |
Type of Resource: | E-Article |
Language: | English |
published: |
Ferrata Storti Foundation (Haematologica)
|
Subjects: |